Integrated Care After Repeated Psychiatric Hospital Stays - Evaluation of an Interdisciplinary Treatment Program - Trial NCT06411951
Access comprehensive clinical trial information for NCT06411951 through Pure Global AI's free database. This phase not specified trial is sponsored by Michael Rufer and is currently Enrolling by invitation. The study focuses on High Utilization / Heavy Use,Psychiatric Hospitalization,Rehospitalization,Intensive Care Psychiatric Disorder,Chronic Psychiatric Disorder,Health Care Utilization. Target enrollment is 90 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Participation in the INTUK care offer at Klinik Zugersee
Observational
other
Sponsor & Location
Michael Rufer
Triaplus AG Klinik Zugersee - Zentrum für Psychiatrie und Psychotherapie
Timeline & Enrollment
N/A
Jun 01, 2023
Dec 31, 2027
Primary Outcome
Admission rate
Summary
The study aims to evaluate the treatment effects as well as inhibiting and promoting factors
 in the implementation of the new INTUK care offer in a sample of heavy users, i.e.
 psychiatric patients with 4 or more prior inpatient admissions at Klinik Zugersee, by means
 of a longitudinal, prospective-retrospective study. For this purpose, medical records will be
 analysed and participants will be asked to fill out questionnaires addressing different
 aspects of mental health, quality of life and patient satisfaction. In addition,
 semi-structured interviews will be conducted with a subset of patients as well as staff
 members of the INTUK care offer.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06411951
Non-Device Trial